tenofovir has been researched along with Renal Insufficiency in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (16.25) | 29.6817 |
2010's | 54 (67.50) | 24.3611 |
2020's | 13 (16.25) | 2.80 |
Authors | Studies |
---|---|
Drak, D; Gowers, A; Gracey, DM; Lin, J | 1 |
Chadwick, DR; Durrani, M; Hardy, Y; Hunt, M; Mitchelmore, R; Owusu, DO; Payne, BAI; Phillips, R | 1 |
Burger, DM; Colbers, A; Grintjes, K; Jacobs, TG; Nieuwenstein, T; Zino, L | 1 |
Godman, B; Kalemeera, F; Rennie, T; Stergachis, A | 1 |
Bouitbir, J; Bugarski, M; Connolly, J; Haenni, D; Hall, AM; Hung, RKY; Hunt, M; Jankovic, N; Nlandu-Khodo, S; Payne, BAI; Pearson, A; Post, FA; Sachdeva, A | 1 |
Asselin, J; Carter, A; Chen, M; Donovan, B; Gracey, DM; Grulich, A; Guy, R; Heron, JE; Lewis, DA; McManus, H; O'Connor, CC; Ryan, K; Ryder, N; Stoove, M; Templeton, DJ; Varma, R; Vickers, T; Wright, E | 1 |
Singh, S | 1 |
Althaus, T; Banchongkit, S; Halue, G; Harrison, L; Jourdain, G; Lallemant, M; Lertkoonalak, R; Liegeon, G; Mary, JY; Nechba, A; Nilmanat, A; Pathipvanich, P; Thongpaen, S; Yutthakasemsunt, N | 1 |
Agarwal, K; Ahn, SH; Bae, H; Buti, M; Chan, HLY; Chen, CY; Chuang, WL; Flaherty, JF; Fung, S; Gaggar, A; Lampertico, P; Lau, A; Lim, YS; Liu, Y; Ma, X; Ramji, A; Subramanian, GM; Suri, V; Tak, WY; Tam, E; Tan, SK; Trinh, H; Wu, G; Yoon, SK | 1 |
Burger, DM; Dams, K; Francque, S; Jorens, PG; Vanwolleghem, T; Weyler, J | 1 |
Byakika-Kibwika, P; Kalyesubula, R; Nyende, L; Sekasanvu, E | 1 |
Berg, T; Botros, I; Buti, M; Flaherty, JF; Jump, B; Lampertico, P; Op den Brouw, ML; Pathil, A; Petersen, J; Ramroth, H; Ryder, SD; van Troostenburg, A; Zoulim, F | 1 |
Abraham, P; Isaac, B; Ramamoorthy, H | 1 |
Hadigan, CM; Hazra, R; Jones, SE; Kopp, JB; Mattingly, AS; Purdy, JB; Reynolds, JC; Unsal, AB | 1 |
Hsu, YC; Nguyen, MH; Wei, MT | 1 |
Anderson, PL; Bacon, O; Buchbinder, SP; Chege, W; Cohen, SE; Coleman, ME; Doblecki-Lewis, S; Elion, R; Kolber, MA; Liu, AY; Shlipak, M; Tang, EC; Vittinghoff, E | 1 |
Kwak, IS; Lee, JE; Lee, S; Lee, SH; Song, SH | 1 |
Baeten, JM; Celum, CL; Heffron, R; Katabira, E; Kiarie, J; Mugo, NR; Mugwanya, KK; Ronald, A; Wyatt, C | 1 |
Bedimo, R; Bress, AP; Crook, J; Esker, S; Knippenberg, K; LaFleur, J; Nyman, H; Rosenblatt, L; Tebas, P | 1 |
Dorward, J; Drain, PK; Garrett, N; Karim, QA; Samsunder, N; Yende-Zuma, N | 1 |
Leufkens, HGM; Mantel-Teeuwisse, AK; Mavhunga, F; Mekonen, TT; Mengistu, A; Rennie, T; Ruswa, N; Sagwa, EL | 1 |
Chikwapulo, B; Evans, R; Ngwira, B; Sagno, JB | 1 |
Grossi, G; Lampertico, P; Loglio, A; Viganò, M | 1 |
Baymbajav, B; Cha, SW; Cho, YD; Jang, JY; Jeong, SW; Jung, WJ; Kim, BS; Kim, HS; Kim, SG; Kim, YS; Lee, HJ; Lee, SH; Park, S; Park, SJ; Park, WY | 1 |
Chang, ET; Cheung, R; Chung, M; Henry, L; Hoang, J; Jeong, D; Le, AK; Lee, MH; Nguyen, MH; Trinh, S; Wang, U | 1 |
Álvarez, H; Díaz-Cambre, H; García-González, J; Llibre, JM; Mariño, A; Valcarce, N | 1 |
Ahn, SH; Cho, YK; Choi, W; Han, KH; Hong, GY; Jang, JY; Jin, SY; Jung, YK; Kim, DJ; Kim, HS; Kim, JH; Kim, KH; Kim, MY; Kim, W; Kim, YJ; Kweon, YO; Lee, BS; Lee, JW; Lee, KS; Lee, WS; Lim, YS; Park, NH; Park, SJ; Sohn, JH; Um, SH; Yang, JM; Yim, HJ; Yoon, SK | 1 |
Arribas, JR; Brainard, D; Carter, C; Clarke, AE; Das, M; Elion, RA; Eron, JJ; Esser, S; Guo, S; Gupta, SK; Martin, H; Mudrikova, T; Negredo, E; Orkin, C; Podzamczer, D; Post, FA; Pozniak, AL; Rockstroh, JK; Sax, PE; SenGupta, D; Stellbrink, HJ; Waters, L; Wohl, DA; Zhong, L | 1 |
Amanda, TO; Kpossou, AR; Séhonou, J; Sokpon, CNM; Vigan, J; Vignon, RK | 1 |
Maponga, CC; Morse, GD; Mtisi, TJ; Ndhlovu, CE | 1 |
Dodoo, ANO; Lartey, M; Leufkens, HGM; Mantel-Teeuwisse, AK; Nartey, ET; Tetteh, RA; Yankey, BA | 1 |
Asano, T; Fujiki, K; Furumoto, Y; Hayakawa, Y; Horiuchi, T; Kobayashi, K; Matsumoto, T; Matsuoka, M; Misumi, Y; Miura, N; Nozaka, T; Sakamoto, N | 1 |
Hassoun, G; Kedem, E; Mugrabi, F; Pollack, S; Shahar, E | 1 |
Anastos, K; Bacchetti, P; Baxi, SM; Cohen, M; Gandhi, M; Gange, SJ; Greenblatt, RM; Huang, Y; Minkoff, H; Scherzer, R; Shlipak, MG; Young, M | 1 |
Calmy, A; Chi, BH; Davies, MA; Keiser, O; Mulenga, L; Musonda, P; Mwango, A; Mweemba, A; Stringer, JS; Vinikoor, MJ; Wandeler, G | 1 |
Chi, BH; Emge, D; Mulenga, L; Mweemba, A; Vinikoor, MJ; Wandeler, G; Zanolini, A | 1 |
Aoki, T; Gatanaga, H; Honda, H; Kawasaki, Y; Kikuchi, Y; Kinai, E; Mizushima, D; Nishijima, T; Oka, S; Tanaka, N; Tanuma, J; Teruya, K; Tsukada, K; Watanabe, K; Yazaki, H | 1 |
Bekker, LG; Kamkuemah, M; Kaplan, R; Little, F; Myer, L | 1 |
Abram, ME; Andrade-Villanueva, JF; Beraud, C; Cheng, AK; Fisher, M; Graham, H; Liu, Y; Post, FA; Rhee, MS; Szwarcberg, J; Winston, J | 1 |
Avihingsanon, A; Bowonwatanuwong, C; Cressey, TR; Fletcher, CV; Halue, G; Jaisieng, N; Jourdain, G; Klinbuayaem, V; Leenasirimakul, P; Podany, AT; Sukrakanchana, PO; Tawon, Y | 1 |
Alonso-Vega, GG; Esteban, LL; Ferrández, JS; García, JR; García, TM; Quesada, PR; Sánchez, RV | 1 |
Aleman, J; de Fijter, CW; Franssen, EJ; van den Berk, GE | 1 |
Antierens, A; Chinnakali, P; Das, M; Fernandez, M; Harries, AD; Htwe, PS; Kyaw, NT; Shetty, S; Soe, KP; Woodman, M; Zuu, MK | 1 |
Almeida, JR; Esberard, EB; Lopes, PF; Lugon, JR; Medeiros, T; Mendes, GF; Patricio, JA; Silva, AA | 1 |
Abraham, AG; Baxi, SM; Cohen, M; Greenblatt, RM; Minkoff, H; Scherzer, R; Sharma, A; Shlipak, MG; Young, MA | 1 |
Abram, ME; Arribas, JR; Avihingsanon, A; Benson, P; Bloch, M; Cheng, A; Chetchotisakd, P; Crofoot, G; Custodio, JM; Fordyce, MW; Gathe, J; Gupta, SK; Lichtenstein, K; McCallister, S; Post, FA; Pozniak, A; Ramgopal, M; SenGupta, D; Wei, X | 1 |
Alcantarini, C; Bonora, S; Calcagno, A; Cusato, J; D'Avolio, A; Di Perri, G; Lucchiari, M; Marinaro, L; Mengozzi, G; Simiele, M; Tettoni, MC; Trentini, L | 1 |
Gatanaga, H; Kawasaki, Y; Kikuchi, Y; Kurosawa, T; Nishijima, T; Oka, S; Tanaka, N | 1 |
Baeten, J; Branch, A; Celum, C; Donnell, D; Kiarie, J; Mugo, N; Mugwanya, K; Nickolas, T; Ronald, A; Tappero, J; Wyatt, C; Yin, M | 1 |
Kaleebu, P; Kasamba, I; Kazooba, P; Mayanja, BN; Munderi, P; Salome, T; Were, J | 1 |
Birbal, S; Dheda, M; Ojewole, E; Oosthuizen, F | 1 |
He, J; Li, K; Li, W; Ning, HB; Shang, J; Zeng, YL | 1 |
Anderson, PL; Flynn, PM; Gordon, CM; Havens, PL; Hazra, R; Hosek, SG; Kapogiannis, BG; Liu, N; Mulligan, K; Pan, CG; Rutledge, B; Schuster, GU; Seifert, SM; Stephensen, CB; Van Loan, MD; Wilson, CM; Woodhouse, LR | 1 |
Bregigeon, S; Faucher, O; Obry-Roguet, V; Poizot-Martin, I; Solas, C; Tamalet, C | 1 |
Kaplan, BS; Meyers, KE; Rutstein, RM; Shah, SS; Steenhoff, AP; Wood, SM | 1 |
Albalater, M; Back, D; Cuenca, L; Egan, D; González-Pardo, G; Khoo, S; Labarga, P; Morello, J; Owen, A; Rodríguez-Nóvoa, S; Soriano, V | 1 |
Beijnen, JH; Huitema, AD; Jansen, RS; Mulder, JW; Smits, PH; Ter Heine, R; van Gorp, EC; Wagenaar, JF | 1 |
Bonnet, F; Dabis, F; Déti, EK; Dupon, M; Lawson-Ayayi, S; Malvy, D; Morlat, P; Neau, D; Pellegrin, JL; Tchamgoué, S; Thiébaut, R | 1 |
D'Agati, VD; Herlitz, LC; Markowitz, GS; Mohan, S; Radhakrishnan, J; Stokes, MB | 1 |
De Beaudrap, P; Delaporte, E; Diallo, MB; Diouf, A; Etard, JF; Girard, PM; Guèye, NF; Kane, CT; Landman, R; Ndiaye, I; Sow, PS | 1 |
Bowonwatanuwong, C; Chaisiri, K; Kasettratat, N; Kiertiburanakul, S | 1 |
Perazella, MA | 1 |
Darin, KM; Gerzenshtein, L; O'Donnell, EP; Palella, FJ; Postelnick, MJ; Scarsi, KK | 1 |
Brooks, JT; Bush, T; Conley, L; Hammer, J; Henry, K; Kojic, EM; Mondy, K; Overton, ET; Patel, P; Rhame, F | 1 |
Brennan, A; Evans, D; Fox, M; Ive, P; Maotoe, T; Maskew, M; Naicker, S; Sanne, I | 1 |
Chimsuntorn, S; Manosuthi, W; Nilkamhang, S; Prasithsirikul, W; Sungkanuparph, S; Tantanathip, P | 1 |
Cocohoba, J; Gruta, C; John, MD; Lao, CK | 1 |
Chong, WH; Collins, MT; Gara, N; Ghany, MG; Hoofnagle, JH; Jake Liang, T; Kleiner, DE; Zhao, X | 1 |
Akinkuotu, A; Chasela, C; Hosseinipour, MC; Jamieson, DJ; Johnson, DC; King, CC; Kourtis, AP; Maliwichi, M; Moses, A; Mwafongo, A; van der Horst, C | 1 |
Baak, BC; Bakker, CM; Beuers, UH; Brouwer, JT; Buster, EH; Drenth, JP; Honkoop, P; Janssen, HL; Kerbert-Dreteler, MJ; Koek, GH; Tan, AC; van der Spek, BW; van Erpecum, KJ; van Hoek, B; van Nieuwkerk, KM; van Soest, H; Vrolijk, JM | 1 |
Fouqueray, B; Girard, PM; Meynard, JL; Monge, M; Mougenot, B; Ronco, P; Rossert, J; Verhelst, D | 1 |
Bourgarit, A; Droz, D; Furco, A; Karras, A; Lafaurie, M; Legendre, C; Martinez, F; Molina, JM; Sereni, D | 1 |
Perazella, MA; Rifkin, BS | 1 |
Bower, M; Gazzard, B; Jones, R; Mandalia, S; Moyle, G; Nelson, M; Stebbing, J | 1 |
Fine, DM | 1 |
Bedford, J; Braden, G; Hoffman, R; Morris, A; Pizzoferrato, T; Zimmermann, AE | 1 |
Flaherty, JF; Kearney, BP; Shah, J; Yale, K; Zhong, L | 1 |
Adachi, M; Imaoka, T; Kusuhara, H; Schuetz, JD; Sugiyama, Y; Takeuchi, K | 1 |
Cihlar, T; Ray, AS | 1 |
Ahya, SN; Kanwar, YS; Palella, F; Patel, SM; Zembower, TR | 1 |
8 review(s) available for tenofovir and Renal Insufficiency
Article | Year |
---|---|
Medication safety in chronic kidney disease.
Topics: Adenine; COVID-19; Humans; Kidney; Renal Insufficiency; Renal Insufficiency, Chronic; Tenofovir | 2023 |
Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics.
Topics: Adenine; Age Factors; Alanine; Antiviral Agents; Bone Density; Clinical Decision-Making; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Kidney; Male; Osteoporosis; Patient Safety; Pregnancy; Renal Insufficiency; Risk Factors; Tenofovir; Treatment Outcome | 2017 |
Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?
Topics: Adenine; Alanine; Antiviral Agents; Bone Density; Dose-Response Relationship, Drug; Hepatitis B, Chronic; Humans; Prodrugs; Renal Insufficiency; Tenofovir | 2018 |
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Anti-HIV Agents; Child; Female; Humans; Incidence; Male; Middle Aged; Renal Insufficiency; Tenofovir; Young Adult | 2019 |
Tenofovir-associated kidney disease in Africans: a systematic review.
Topics: Africa; Anti-HIV Agents; HIV Infections; Humans; Kidney; Kidney Diseases; Renal Insufficiency; Tenofovir | 2019 |
Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males.
Topics: Adenine; Adolescent; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; Blood Urea Nitrogen; CD4 Lymphocyte Count; Creatinine; Diagnosis, Differential; HIV Infections; Humans; Hypophosphatemia; Infectious Disease Transmission, Vertical; Male; Organophosphonates; Renal Insufficiency; Reverse Transcriptase Inhibitors; Rickets; Risk Factors; Safety; Tenofovir | 2009 |
Editorial comment: tenofovir nephrotoxicity--vigilance required.
Topics: Adenine; Fanconi Syndrome; Glycosuria; HIV Infections; Humans; Hypokalemia; Hypophosphatemia; Organophosphonates; Proteinuria; Renal Insufficiency; Reverse Transcriptase Inhibitors; Tenofovir | 2005 |
Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.
Topics: Adenine; Aged; Anti-HIV Agents; Creatinine; Drug Interactions; Humans; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Risk Factors; Tenofovir | 2006 |
10 trial(s) available for tenofovir and Renal Insufficiency
Article | Year |
---|---|
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study.
Topics: Adenine; Alanine; Antiviral Agents; Bone Density; Creatinine; DNA, Viral; Double-Blind Method; Drug Substitution; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Nasopharyngitis; Renal Insufficiency; Respiratory Tract Infections; Sustained Virologic Response; Tenofovir | 2020 |
Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Creatinine; Female; Humans; Kenya; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Pre-Exposure Prophylaxis; Renal Insufficiency; Tenofovir; Uganda; Young Adult | 2018 |
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.
Topics: Absorptiometry, Photon; Adult; Alanine Transaminase; Antiviral Agents; Bone Density; Bone Diseases, Metabolic; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Glomerular Filtration Rate; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hip; Humans; Lumbar Vertebrae; Male; Maleates; Middle Aged; Organophosphonates; Osteoporosis; Renal Insufficiency; Sustained Virologic Response; Tenofovir; Treatment Outcome | 2019 |
Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment.
Topics: Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Cytoplasm; Female; HIV Infections; Humans; Male; Middle Aged; Plasma; Renal Insufficiency; Tenofovir; Time Factors | 2015 |
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
Topics: Adult; Albuminuria; Bone Density; Cobicistat; Drug Substitution; Drug Therapy, Combination; Emtricitabine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Proteinuria; Quinolones; Renal Insufficiency; Tenofovir | 2016 |
Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
Topics: Adolescent; Adult; Anti-HIV Agents; Chemoprevention; Female; HIV Infections; Humans; Male; Middle Aged; Placebos; Pre-Exposure Prophylaxis; Renal Insufficiency; Tenofovir; Urinalysis; Young Adult | 2016 |
The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis.
Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Creatinine; Cross-Sectional Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Tenofovir; Uganda; Young Adult | 2016 |
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
Topics: Adolescent; Anti-HIV Agents; Bone Density; Creatinine; Emtricitabine; Fibroblast Growth Factor-23; Glomerular Filtration Rate; HIV Infections; Homosexuality, Male; Humans; Kidney; Male; Parathyroid Hormone; Pre-Exposure Prophylaxis; Renal Insufficiency; Tenofovir; Young Adult | 2017 |
Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Mass Index; CD4 Lymphocyte Count; Creatinine; Cyclopropanes; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Malawi; Male; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Renal Insufficiency; Tenofovir | 2012 |
Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment.
Topics: Adenine; Adult; Aged; Drug Administration Schedule; Drug Monitoring; Female; Humans; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Renal Dialysis; Renal Insufficiency; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir | 2006 |
62 other study(ies) available for tenofovir and Renal Insufficiency
Article | Year |
---|---|
Fanconi syndrome in a patient receiving pre-exposure prophylaxis for HIV infection: case report.
Topics: Anti-HIV Agents; Emtricitabine; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Pre-Exposure Prophylaxis; Proteinuria; Renal Insufficiency; Tenofovir | 2022 |
Renal mitochondrial toxicity: effects of thymidine analogues and tenofovir disoproxil fumarate in African people with HIV.
Topics: Anti-HIV Agents; Ghana; HIV Infections; Humans; Mitochondria; Renal Insufficiency; Tenofovir; Thymidine | 2022 |
Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report.
Topics: Anti-HIV Agents; Emtricitabine; HIV Infections; Humans; Pre-Exposure Prophylaxis; Renal Insufficiency; Tenofovir | 2023 |
Effect of tenofovir containing ART on renal function in patients with moderate/severe reduced creatinine clearance at baseline: A retrospective study at two referral hospitals in Namibia.
Topics: Anti-HIV Agents; Creatinine; HIV Infections; Humans; Kidney; Male; Namibia; Renal Insufficiency; Retrospective Studies; Tenofovir | 2023 |
Integration of High-Throughput Imaging and Multiparametric Metabolic Profiling Reveals a Mitochondrial Mechanism of Tenofovir Toxicity.
Topics: Antiviral Agents; Humans; Kidney; Metabolomics; Mitochondria; Renal Insufficiency; Tenofovir | 2023 |
Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cohort Studies; Emtricitabine; HIV Infections; Humans; Pre-Exposure Prophylaxis; Renal Insufficiency; Tenofovir | 2023 |
Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors.
Topics: Adult; Anti-HIV Agents; Asian People; Body Weight; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Renal Insufficiency; Tenofovir; Thailand; Zidovudine | 2019 |
A pharmacokinetic study to guide dosing of tenofovir disoproxil fumarate during different modalities of renal replacement therapy.
Topics: Antiviral Agents; Drug Administration Schedule; Hemofiltration; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Renal Insufficiency; Renal Replacement Therapy; Tenofovir | 2020 |
Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glycosuria; HIV Infections; Humans; Hypercalcemia; Hyperkalemia; Hyperphosphatemia; Hypocalcemia; Hypokalemia; Hypophosphatemia; Lamivudine; Male; Middle Aged; Prevalence; Proteinuria; Renal Insufficiency; Tenofovir; Uganda | 2020 |
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Tenofovir; Treatment Outcome; Young Adult | 2020 |
Melatonin protects against tenofovir-induced nephrotoxicity in rats by targeting multiple cellular pathways.
Topics: Animals; Antiviral Agents; Hepatitis B, Chronic; HIV Infections; Humans; Male; Melatonin; Metabolic Networks and Pathways; Models, Animal; Rats; Renal Insufficiency; Tenofovir | 2021 |
Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life.
Topics: Absorptiometry, Photon; Acid-Base Equilibrium; Adult; Age of Onset; Albuminuria; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Case-Control Studies; Creatinine; Cross-Sectional Studies; Didanosine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Function Tests; Longitudinal Studies; Male; Osteocalcin; Prospective Studies; Proteinuria; Renal Insufficiency; Risk Factors; Stavudine; Tenofovir; Time Factors; Young Adult | 2017 |
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Creatinine; Disease Transmission, Infectious; Emtricitabine; Female; Glomerular Filtration Rate; HIV Infections; Homosexuality, Male; Humans; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Pre-Exposure Prophylaxis; Prospective Studies; Proteins; Renal Insufficiency; Tenofovir; Transgender Persons; United States; Urinalysis; Young Adult | 2018 |
Incidence and risk factors for tenofovir-associated nephrotoxicity among human immunodeficiency virus-infected patients in Korea.
Topics: Adult; Anti-Retroviral Agents; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Renal Insufficiency; Republic of Korea; Retrospective Studies; Risk Factors; Tenofovir | 2019 |
Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Renal Insufficiency; Risk Assessment; Tenofovir; Veterans; Young Adult | 2018 |
Clinic-Based Evaluation of a Point-of-Care Creatinine Assay to Screen for Renal Impairment Among HIV-Positive Patients Receiving Tenofovir Disoproxil Fumarate.
Topics: Adult; Anti-HIV Agents; Creatinine; Diagnostic Tests, Routine; Female; HIV Infections; Humans; Male; Point-of-Care Systems; Prospective Studies; Renal Insufficiency; Tenofovir | 2018 |
Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Namibia; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Community Health Centers; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Incidence; Malawi; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Risk Factors; Tenofovir | 2018 |
Effect of tenofovir on renal function in patients with chronic hepatitis B.
Topics: Adult; Antiviral Agents; Bilirubin; Cohort Studies; Creatinine; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Male; Middle Aged; Renal Insufficiency; Tenofovir | 2018 |
Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Biostatistics; Creatinine; Female; Glomerular Filtration Rate; Guanine; Hepatitis B, Chronic; Humans; Longitudinal Studies; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Tenofovir | 2019 |
Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide.
Topics: Adenine; Alanine; Anti-HIV Agents; Cobicistat; Drug Combinations; Drug Overdose; Emtricitabine; HIV Infections; Humans; Male; Middle Aged; Quinolones; Renal Insufficiency; Suicide, Attempted; Tenofovir | 2019 |
[Hepatitis B and renal failure: prevalence and associated factors in National University Hospital Center of Cotonou].
Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Benin; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B Surface Antigens; Hospitals, University; Humans; Hypertension; Male; Middle Aged; Prevalence; Renal Insufficiency; Risk Factors; Tenofovir; Young Adult | 2018 |
Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Female; Ghana; HIV Infections; Humans; Incidence; Kidney; Kidney Function Tests; Male; Middle Aged; Renal Insufficiency; Tenofovir | 2019 |
A case of esophageal cancer with human immunodeficiency virus infection that progressed rapidly after neoadjuvant chemoradiotherapy.
Topics: Aged; Alkynes; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoxazines; Chemoradiotherapy; Cisplatin; Cyclopropanes; Deglutition Disorders; Disease Progression; Drug Interactions; Emtricitabine; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fatal Outcome; Female; Fluorouracil; Gastrostomy; HIV Infections; Humans; Neoadjuvant Therapy; Neoplasm Staging; Renal Insufficiency; RNA, Viral; Tenofovir; Viral Load | 2020 |
[Crucial risk factors for renal function deterioration of HIV-infected patients at the AIDS Clinic in Rambam Hospital].
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Coinfection; Female; Glomerular Filtration Rate; Hepatitis C; HIV Infections; Humans; Israel; Male; Medical Records, Problem-Oriented; Middle Aged; Models, Statistical; Organophosphonates; Renal Insufficiency; Retrospective Studies; Risk Factors; Tenofovir | 2013 |
Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women.
Topics: Adenine; Adult; Age Factors; Anti-HIV Agents; Body Mass Index; Cohort Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Middle Aged; Organophosphonates; Prospective Studies; Renal Insufficiency; Ritonavir; Tenofovir; Young Adult | 2014 |
Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Male; Organophosphonates; Renal Insufficiency; Tenofovir; Zambia | 2014 |
Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults.
Topics: Adenine; Adolescent; Adult; Africa; Anti-HIV Agents; Coinfection; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; HIV; Humans; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Tenofovir; Young Adult | 2014 |
Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Cohort Studies; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Longitudinal Studies; Male; Organophosphonates; Renal Insufficiency; Tenofovir; Tokyo | 2014 |
Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
Topics: Adenine; Adult; Age Factors; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Logistic Models; Male; Middle Aged; Organophosphonates; Prevalence; Primary Health Care; Renal Insufficiency; Reverse Transcriptase Inhibitors; South Africa; Tenofovir | 2015 |
Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairment.
Topics: Adenine; Adult; Anti-HIV Agents; Carbamates; Cobicistat; Cohort Studies; Deoxycytidine; Emtricitabine; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Quinolones; Renal Insufficiency; Tenofovir; Thiazoles; Treatment Outcome | 2015 |
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Glomerular Filtration Rate; HIV Infections; Humans; Incidence; Longitudinal Studies; Male; Renal Insufficiency; Retrospective Studies; Risk Factors; Spain; Tenofovir | 2015 |
Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need?
Topics: Antiviral Agents; Coinfection; Hemodialysis Solutions; Hepatitis B; HIV Infections; Humans; Peritoneal Dialysis; Renal Insufficiency; Serum; Tenofovir | 2015 |
Low Incidence of Renal Dysfunction among HIV-Infected Patients on a Tenofovir-Based First Line Antiretroviral Treatment Regimen in Myanmar.
Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Myanmar; Renal Insufficiency; Risk Factors; Switzerland; Tenofovir | 2015 |
Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
Topics: Adult; Albuminuria; Alkaline Phosphatase; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Electrolytes; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency; Serum Albumin; Tenofovir; Urea; Uric Acid; Vitamin D | 2016 |
Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.
Topics: Adult; Aged; Anti-HIV Agents; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Middle Aged; Prospective Studies; Renal Insufficiency; Tenofovir; Young Adult | 2016 |
Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment.
Topics: Adult; Anti-HIV Agents; Asymptomatic Diseases; Cross-Sectional Studies; Female; HIV Infections; Humans; Kidney Function Tests; Male; Middle Aged; Plasma; Renal Insufficiency; Tenofovir; Urine | 2016 |
Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
Topics: Adult; Antiviral Agents; beta 2-Microglobulin; Biomarkers; Female; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Renal Insufficiency; Tenofovir | 2016 |
Adverse drug reactions associated with antiretroviral therapy in South Africa.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Female; Gynecomastia; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Renal Insufficiency; Retrospective Studies; South Africa; Stavudine; Tenofovir; Zidovudine | 2016 |
[Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
Topics: Adult; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Female; Guanine; Hepatitis B, Chronic; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Predictive Value of Tests; Renal Insufficiency; Retinol-Binding Proteins; Serum Albumin; Tenofovir; Treatment Outcome | 2016 |
Impact of tenofovir dose adjustment on both estimated glomerular filtration rate and tenofovir trough concentration.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Severity of Illness Index; Tenofovir | 2017 |
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
Topics: Adenine; Adult; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Female; Gene Frequency; HIV Infections; Homozygote; Humans; Kidney Tubules; Male; Molecular Sequence Data; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters, Sodium-Independent; Organophosphonates; Polymorphism, Genetic; Renal Insufficiency; Tenofovir | 2009 |
Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failure.
Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Withholding Treatment | 2009 |
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France.
Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Creatinine; Epidemiologic Methods; Female; France; HIV Infections; Humans; Hypertension; Indinavir; Kidney; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Tenofovir | 2010 |
Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Topics: Acute Kidney Injury; Adenine; Adult; Anti-HIV Agents; Biopsy; Drug Administration Schedule; Female; Glycosuria; HIV Infections; HIV-1; Humans; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Male; Microscopy, Electron; Middle Aged; Mitochondria; New York City; Organophosphonates; Proteinuria; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Tenofovir; Time Factors | 2010 |
Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Incidence; Kidney; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Senegal; Tenofovir | 2010 |
Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight.
Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; Body Weight; Cohort Studies; Drug Interactions; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Retrospective Studies; Risk Factors; Tenofovir; Thailand | 2010 |
Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Topics: Acute Kidney Injury; Adenine; Animals; Anti-HIV Agents; Drug Administration Schedule; Glycosuria; HIV Infections; HIV-1; Humans; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Mitochondria; Organophosphonates; Proteinuria; Renal Dialysis; Renal Insufficiency; Tenofovir; Time Factors | 2010 |
Low incidence of renal impairment observed in tenofovir-treated patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Retrospective Studies; Risk Factors; Tenofovir | 2011 |
Cystatin C and baseline renal function among HIV-infected persons in the SUN Study.
Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Cystatin C; Female; Glomerular Filtration Rate; Hepatitis C; HIV Seropositivity; Humans; Hypertension; Male; Organophosphonates; Prospective Studies; Renal Insufficiency; Ritonavir; Tenofovir | 2012 |
Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir.
Topics: Adenine; Adult; Anti-HIV Agents; Cohort Studies; Creatinine; Female; HIV Infections; Humans; Kidney; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Risk Factors; South Africa; Tenofovir | 2011 |
Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Anti-Retroviral Agents; Female; HIV Infections; HIV-1; Humans; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Protease Inhibitors; Renal Insufficiency; Retrospective Studies; Tenofovir; Thailand | 2011 |
A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians.
Topics: Adenine; Adult; Anti-HIV Agents; Black or African American; Creatinine; Drug Monitoring; Female; Glomerular Filtration Rate; HIV; HIV Infections; Humans; Kidney; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Tenofovir; United States; White People; Withholding Treatment | 2011 |
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.
Topics: Adenine; Adult; Aged; Antiviral Agents; Biomarkers; Creatinine; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Kidney Tubules; Male; Middle Aged; Organophosphonates; Phosphates; Renal Insufficiency; Tenofovir; Time Factors; Uric Acid | 2012 |
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
Topics: Adenine; Antiviral Agents; Drug Approval; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Netherlands; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Renal Insufficiency; Telbivudine; Tenofovir; Thymidine | 2012 |
Fanconi syndrome and renal failure induced by tenofovir: a first case report.
Topics: Adenine; Anti-HIV Agents; Fanconi Syndrome; Female; HIV Seropositivity; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir | 2002 |
Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
Topics: Acidosis; Adenine; Adult; Anti-HIV Agents; Creatinine; Diabetes Insipidus, Nephrogenic; Drug Monitoring; Fanconi Syndrome; Glycosuria; HIV Infections; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Proteinuria; Renal Insufficiency; Tenofovir | 2003 |
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Fanconi Syndrome; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir | 2004 |
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study.
Topics: Adenine; Albuminuria; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Creatinine; Follow-Up Studies; HIV Infections; Humans; Organophosphonates; Proteinuria; Renal Insufficiency; Tenofovir | 2004 |
Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
Topics: Adenine; Adenosine Triphosphate; Animals; Antiviral Agents; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Kidney; Mice; Mice, Knockout; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organophosphonates; Osmosis; Renal Insufficiency; Tenofovir; Tissue Distribution | 2007 |
Unlikely association of multidrug-resistance protein 2 single-nucleotide polymorphisms with tenofovir-induced renal adverse events.
Topics: Adenine; Anti-HIV Agents; Confounding Factors, Epidemiologic; HIV Infections; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organophosphonates; Point Mutation; Polymorphism, Single Nucleotide; Renal Insufficiency; Tenofovir | 2007 |
Early onset of tenofovir-induced renal failure: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Antiretroviral Therapy, Highly Active; Biopsy; HIV Infections; Humans; Liver; Male; Organophosphonates; Renal Insufficiency; Tenofovir; Time Factors; Treatment Outcome | 2007 |